KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Other financing activities (2016 - 2025)

Historic Other financing activities for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to -$6.2 million.

  • Charles River Laboratories International's Other financing activities rose 5374.28% to -$6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.2 million, marking a year-over-year increase of 3595.17%. This contributed to the annual value of -$31.4 million for FY2024, which is 65855.25% down from last year.
  • Charles River Laboratories International's Other financing activities amounted to -$6.2 million in Q3 2025, which was up 5374.28% from -$6.5 million recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Other financing activities ranged from a high of $28.7 million in Q1 2021 and a low of -$15.5 million during Q2 2022
  • Moreover, its 5-year median value for Other financing activities was -$2.2 million (2024), whereas its average is -$1.2 million.
  • Its Other financing activities has fluctuated over the past 5 years, first skyrocketed by 7915000.0% in 2021, then tumbled by 8575000.0% in 2022.
  • Charles River Laboratories International's Other financing activities (Quarter) stood at $2000.0 in 2021, then plummeted by 85750.0% to -$1.7 million in 2022, then crashed by 141.97% to -$4.1 million in 2023, then dropped by 9.58% to -$4.5 million in 2024, then crashed by 37.14% to -$6.2 million in 2025.
  • Its last three reported values are -$6.2 million in Q3 2025, -$6.5 million for Q2 2025, and -$4.5 million during Q4 2024.